rabbit anti human tlr2 polyclonal antibody (Cell Signaling Technology Inc)
Structured Review

Rabbit Anti Human Tlr2 Polyclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 210 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti human tlr2 polyclonal antibody/product/Cell Signaling Technology Inc
Average 95 stars, based on 210 article reviews
Images
1) Product Images from "Glucose-Based Peritoneal Dialysis Fluids Downregulate Toll-Like Receptors and Trigger Hyporesponsiveness to Pathogen-Associated Molecular Patterns in Human Peritoneal Mesothelial Cells ▿ "
Article Title: Glucose-Based Peritoneal Dialysis Fluids Downregulate Toll-Like Receptors and Trigger Hyporesponsiveness to Pathogen-Associated Molecular Patterns in Human Peritoneal Mesothelial Cells
Journal: Clinical and Vaccine Immunology : CVI
doi: 10.1128/CVI.00453-09
Figure Legend Snippet: Glucose-based peritoneal dialysis solutions decrease TLR2 and TLR4 expression in human peritoneal mesothelial cells. Cells were treated with 1.5% Dianeal, 2.5% Dianeal, 4.25% Dianeal, and 7.5% icodextrin (Extraneal) for 6, 12, 24, 36, and 48 h for mRNA expression and for 24, 48, and 72 h for protein expression. Real-time PCR and immunoblot analyses were used to determine the TLR2 and TLR4 mRNA and protein expression levels. Incubation of cells with 1.5% Dianeal, 2.5% Dianeal, 4.25% Dianeal, and 7.5% icodextrin for 6 and 12 h did not influence TLR2 (A) and TLR4 (B) mRNA expression. However, at 24, 36, and 48 h, TLR2 and TLR4 mRNA expression in the glucose-based PD solution treatment groups was significantly downregulated compared to that in the control group (P < 0.01). (C) In addition, incubation of cells with 1.5% Dianeal, 2.5% Dianeal, 4.25% Dianeal, and 7.5% icodextrin for 24 h did not influence TLR2 and TLR4 protein expression. However, at 48 (D) and 72 (E) h, TLR2 and TLR4 protein expression in the glucose-based PD solution treatment groups was significantly downregulated compared to that in the control group (P < 0.05). Icodextrin-based PD solutions did not influence TLR2 and TLR4 expression. (F) Cells were analyzed at 48 h by immunofluorescence with anti-TLR2 and anti-TLR4 antibodies, and the intensity values of the cells were measured with LSM 510 confocal software. The positions of the nuclei are indicated by DAPI (4′,6-diamidino-2-phenylindole) fluorescence. Data are expressed as means ± SD for three individual experiments. D1.5%, D2.5%, D4.25%, and E7.5% represent 1.5% Dianeal, 2.5% Dianeal, 4.25% Dianeal, and 7.5% icodextrin, respectively. *, P < 0.05; **, P < 0.01 versus control.
Techniques Used: Expressing, Real-time Polymerase Chain Reaction, Western Blot, Incubation, Control, Immunofluorescence, Software, Fluorescence
Figure Legend Snippet: TLR ligand-induced MAPK and NF-κB signaling is reduced in glucose-based PD solution-treated human peritoneal mesothelial cells. Cells were pretreated with 1.5% Dianeal, 2.5% Dianeal, 4.25% Dianeal, and 7.5% icodextrin (Extraneal) for 48 h and then treated with TLR2 (Pam3CSK4; 250 ng/ml) or TLR4 (LPS; 1 μg/ml) ligand for 60 min. Immunoblot analysis was used to determine phosphorylated p38 MAPK, JNK, and p44/42 MAPK protein levels. Cells pretreated with glucose-based PD solutions that were stimulated with either Pam3CSK4 or LPS exhibited lower levels of phosphorylated p44/42 MAPK (A), JNK (B), p38 (C), and NF-κB p65 (D) than did untreated cells. Cells preincubated with icodextrin-based PD solutions did not shown an influence on TLR ligand-induced MAPK and NF-κB signaling. Data are expressed as means ± SD for three individual experiments. D1.5%, D2.5%, D4.25%, and E7.5% represent 1.5% Dianeal, 2.5% Dianeal, 4.25% Dianeal, and 7.5% icodextrin, respectively. *, P < 0.05; **, P < 0.01 versus control.
Techniques Used: Western Blot, Control
Figure Legend Snippet: Decreased cytokine production in glucose-based PD solution-treated human peritoneal mesothelial cells upon TLR ligand induction. Cells were pretreated with 1.5% Dianeal, 2.5% Dianeal, 4.25% Dianeal, and 7.5% icodextrin (Extraneal) for 48 h and then treated with TLR2 (Pam3CSK4; 250 ng/ml) (A) or TLR4 (LPS; 1 μg/ml) (B) ligand for 2 h. Real-time PCR was used to determine TNF-α and IL-1β mRNA expression. TNF-α and IL-1β syntheses were decreased upon Pam3CSK4 and LPS challenge in glucose-based PD solution-treated mesothelial cells compared to those in the control (untreated cells) (P < 0.05). No significant changes in TNF-α and IL-1β mRNA expression were observed in icodextrin-based PD solution-treated mesothelial cells. Data are expressed as means ± SD for three individual experiments. D1.5%, D2.5%, D4.25%, and E7.5% represent 1.5% Dianeal, 2.5% Dianeal, 4.25% Dianeal, and 7.5% icodextrin, respectively. *, P < 0.05; **, P < 0.01 versus control.
Techniques Used: Real-time Polymerase Chain Reaction, Expressing, Control

